Gbola Amusa analyst CHARDAN CAPITAL

Currently out of the existing stock ratings of Gbola Amusa, 25 are a HOLD (25%), 63 are a BUY (63%), 12 are a SELL (12%).

Gbola Amusa

Work Performance Price Targets & Ratings Chart

Analyst Gbola Amusa works at CHARDAN CAPITAL with a stock forecast success ratio of 64.88% fulfilled within 249.24 days on average.

Gbola Amusa’s has documented 213 price targets and ratings displayed on 25 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on PASG, Passage Bio at 07-Aug-2023.

Wall Street Analyst Gbola Amusa

Analyst best performing recommendations are on SLDB (SOLID BIOSCIENCES LLC).
The best stock recommendation documented was for SLDB (SOLID BIOSCIENCES LLC) at 6/25/2018. The price target of $562.5 was fulfilled within 2 days with a profit of $84.75 (13.09%) receiving and performance score of 65.47.

Average potential price target upside

ADVM Adverum Biotechnologies AXON Axon Enterprise . ESPR Esperion Therapeutics FOLD Amicus Therapeutics KRYS Krystal Biotech LJPC La Jolla Pharmaceutical Co MDCO The Medicines Company MGTX MeiraGTx Holdings PLC MRNA Moderna ONCE Spark Therapeutics PASG Passage Bio PRVB Provention Bio QURE Uniqure NV REGN Regeneron Pharmaceuticals RGNX Regenxbio SAGE Sage Therapeutic SLDB Solid Biosciences LLC VYGR Voyager Therapeutics AGTC Applied Genetic IMVT Immunovant  MCRB Seres Therapeutics TSHA Taysha Gene Therapies  ABUS Arbutus Biopharma Corp FBRX Forte Biosciences VBLT Vascular Biogenics Ltd

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4

$2 (100.00%)

2

23 days ago

2/4 (50%)

$1.5 (60.00%)

52

Buy

6

$4.05 (207.69%)

4

5 months 24 days ago

4/7 (57.14%)

$4.22 (237.08%)

196

Buy

4

$2 (100.00%)

2

6 months 18 days ago

2/4 (50%)

$2.11 (111.64%)

393

Hold

3

$1 (50.00%)

6

1 years 3 months 18 days ago

1/4 (25%)

$2.23 (289.61%)

35

Hold

2

5

2 years 7 months 6 days ago

2/3 (66.67%)

$-0.36 (-15.25%)

70

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Gbola Amusa?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?